In a series of in vitro experiments, PF-429242 was identified as an anti-glioblastoma agent by suppressing SREBP2 activation, inhibiting cell growth and inducing apoptotic cell death (Caruana et al., 2017). The gene discussed is SREBF2; the disease is glioblastoma.